Sembragiline (EVT-302) 是一种具有选择性的 MAO-B 抑制剂，可用于研究阿尔茨海默病（AD）。

Telotristat Etiprate (LX 1606 Hippurate) 是一种色氨酸羟化酶抑制剂，可抑制血清素的产生。

1,2-Dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-5'-phosphate) ammonium是一种膜结合的信号分子，能调节细胞内的膜运输和信号转导。它可用于脂质体制备，以提高化合物的传递效率。此外，1,2-Dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-5'-phosphate) ammonium作为肌动蛋白细胞骨架的协调者，参与细胞形态和运动的调控。

C8 PEG-Ceramide 是一种脂质产品。C8 PEG-Ceramide 可合成脂质双层载体，用于药物递送。

22(S)-hydroxy Cholesterol is a synthetic oxysterol and a modulator of the liver X receptor (LXR). [1] t prevents monocyte chemoattractant protein 1 (MCP-1) expression induced by the LXR agonist GW 3965 in primary hepatocytes and downregulates mRNA expression of the LXR target genes CD36, ACSL1, and SCD-1 in human myotubes. It decreases triacylglycerol and diacylglycerol synthesis from labeled palmitate and acetate, respectively, in human myoblasts by 50% when used at a concentration of 10 uM. 22(S)-hydroxy Cholesterol also reduces fatty acid synthase (FAS) reporter activity through an LXR response element in the promoter region in COS-1 cells transfected with RXRα and LXRα and decreases the expression of MCP-1 and CCR2 in a mouse model of chronic ethanol consumption.[1] [2] Dietary supplementation of 22(S)-hydroxy cholesterol (30 mg/kg per day) leads to less body weight gain and lower liver triacylglycerol levels in rats when fed either a regular chow or high-fat diet as well as preven

2-deoxy-D-Glucose-13C is intended for use as an internal standard for the quantification of 2-deoxy-D-glucose by GC- or LC-MS. 2-deoxy-D-Glucose (T6742) is a glucose antimetabolite and an inhibitor of glycolysis. It inhibits hexokinase,the enzyme that converts glucose to glucose-6-phosphate,as well as phosphoglucose isomerase,the enzyme that converts glucose-6-phosphate to fructose-6-phosphate.

Tisolagiline(KDS2010)是一种强效、高选择性和可逆的MAO-B抑制剂，IC50=8 nM且具有口服活性，可用于治疗阿尔茨海默病和肥胖症。

ML226 是 α/β hydrolase domain-containing protein 11 抑制剂，体外和原位的 IC50s 分别为 15 和 0.68 nM。

93-O17O is a chalcogen-containing cationic lipidoid.1,2It has been used in the generation of lipid nanoparticles (LPNs). LPNs containing 93-O17O localize to the spleen after intravenous injection into mice.1LPNs containing 93-O17O have been used for the delivery of Cre recombinase and ribonucleoproteins for genome editing in mice and for the intratumoral delivery of cGAMP to enhance cross-presentation of tumor antigens.3,2 1.Zhao, X., Chen, J., Qiu, M., et al.Imidazole-based synthetic lipidoids for in vivo mrna delivery into primary T lymphocytesAngew Chem. Int. Ed. Engl.59(45)20083-20089(2020) 2.Chen, J., Qiu, M., Ye, Z., et al.In situ cancer vaccination using lipidoid nanoparticlesSci. Adv.7(19)eabf1244(2021) 3.Li, Y., Yang, T., Yu, Y., et al.Combinatorial library of chalcogen-containing lipidoids for intracellular delivery of genome-editing proteinsBiomaterials178652-662(2018)